Clinical Trials Logo

Clinical Trial Summary

Hyperphosphatemia is still an unresolved problem among hemodialysis patients and significantly increases the risk of death from cardiovascular diseases. Research to date has not answered the question of whether dialysate bicarbonate concentration profiling can improve phosphate removal and its concentration without negative impact on the acid-base balance. This study addressed this issue. Twenty stable hemodialysis patients will enroll to a four-week study during which different dialysate bicarbonate concentration profiles will be used each week. Each patient will undergo the following profiles (one-week periods): Treatment A - stable dialysate bicarbonate concentration Dbic 35 mmol/L during the whole HD session, Treatment B - Dbic 35 mmol/L for the first two hours and Dbic 30 mmol/L for the next two hours and Treatment C - the opposite mid-HD change Dbic from 30 to 35 mmol/L and one week wash-out period between Treatment B and C. We will collect blood samples each hour during the session and one hour after HD completion.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05861700
Study type Interventional
Source Medical University of Warsaw
Contact
Status Completed
Phase N/A
Start date May 21, 2018
Completion date August 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT04229069 - Acid-Base Balance, Metabolism and Minerals N/A
Terminated NCT04030351 - Effect of Dried Fruit Intake on Acid-base Balance N/A
Recruiting NCT03115060 - Comparison of Plasmalyte A, Normal Saline and Ringer Lactate as Intraoperative Fluid During Renal Transplantation Phase 4